Primit Parikh - Nov 23, 2022 Form 4 Insider Report for Transphorm, Inc. (TGAN)

Role
President and COO
Signature
/s/ Cameron McAulay, Attorney-in-Fact
Stock symbol
TGAN
Transactions as of
Nov 23, 2022
Transactions value $
-$8,942
Form type
4
Date filed
11/28/2022, 03:20 PM
Previous filing
Nov 21, 2022
Next filing
Dec 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TGAN Common Stock Options Exercise $4.34K +1K +0.42% $4.34 239K Nov 23, 2022 Direct
transaction TGAN Common Stock Sale -$13.3K -2K -0.84% $6.64 237K Nov 23, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TGAN Stock Option (right to buy) Options Exercise $0 -1K -1.22% $0.00 80.9K Nov 23, 2022 Common Stock 1K $4.34 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale price represents the weighted average sale price of the shares sold ranging from $6.63 to $6.67 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F2 The shares subject to the option are fully vested and exercisable.